Structural and functional characterization of the FimH adhesin of uropathogenic Escherichia coli and its novel applications
- PMID: 34780972
- DOI: 10.1016/j.micpath.2021.105288
Structural and functional characterization of the FimH adhesin of uropathogenic Escherichia coli and its novel applications
Abstract
Type 1 fimbriae are responsible for bacterial pathogenicity and biofilm production, which are important virulence factors in uropathogenic Escherichia coli strains. Many articles are published on fimH, but each examined a specific aspect of this protein. The current review study aimed at focusing on structure and conformational changes and describing efforts to use this protein in novel potential treatments for urinary tract infections, typing methods, and expression systems. The current study was the first review that briefly and effectively examined issues related to fimH adhesin.
Keywords: Conformation switch; FimH antagonists; Uropathogenic E. coli, FimH adhesin; fimH typing.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.Microb Pathog. 2020 Apr;141:103974. doi: 10.1016/j.micpath.2020.103974. Epub 2020 Jan 8. Microb Pathog. 2020. PMID: 31926238
-
Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli.BMC Microbiol. 2024 Sep 14;24(1):344. doi: 10.1186/s12866-024-03472-5. BMC Microbiol. 2024. PMID: 39271999 Free PMC article.
-
Construction and development of FimH lectin domain for rising immune response after injection by uropathogenic E. coli.Hum Antibodies. 2020;28(2):169-178. doi: 10.3233/HAB-200404. Hum Antibodies. 2020. PMID: 32116244
-
Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.Expert Opin Drug Discov. 2017 Jul;12(7):711-731. doi: 10.1080/17460441.2017.1331216. Epub 2017 Jun 2. Expert Opin Drug Discov. 2017. PMID: 28506090 Free PMC article. Review.
-
Uropathogenic Escherichia coli in India-an Overview on Recent Research Advancements and Trends.Appl Biochem Biotechnol. 2021 Jul;193(7):2267-2296. doi: 10.1007/s12010-021-03521-z. Epub 2021 Feb 17. Appl Biochem Biotechnol. 2021. PMID: 33595784 Review.
Cited by
-
Microbial community structure of plant-based meat alternatives.NPJ Sci Food. 2024 May 13;8(1):27. doi: 10.1038/s41538-024-00269-8. NPJ Sci Food. 2024. PMID: 38740858 Free PMC article.
-
Antibiotics in the clinical pipeline as of December 2022.J Antibiot (Tokyo). 2023 Aug;76(8):431-473. doi: 10.1038/s41429-023-00629-8. Epub 2023 Jun 8. J Antibiot (Tokyo). 2023. PMID: 37291465 Free PMC article. Review.
-
The Role of L-Sorbose Metabolism in Enhancing Fitness and Virulence in Escherichia coli Under Acidic Conditions.Infect Drug Resist. 2025 Jun 20;18:3071-3086. doi: 10.2147/IDR.S526664. eCollection 2025. Infect Drug Resist. 2025. PMID: 40556681 Free PMC article.
-
Binding site plasticity regulation of the FimH catch-bond mechanism.Biophys J. 2023 Jul 11;122(13):2744-2756. doi: 10.1016/j.bpj.2023.05.029. Epub 2023 Jun 1. Biophys J. 2023. PMID: 37264571 Free PMC article.
-
A Review of Antibacterial Candidates with New Modes of Action.ACS Infect Dis. 2024 Oct 11;10(10):3440-3474. doi: 10.1021/acsinfecdis.4c00218. Epub 2024 Jul 17. ACS Infect Dis. 2024. PMID: 39018341 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical